Responses
Clinical/translational cancer immunotherapy
Original research
Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib
Compose a Response to This Article
Other responses
No responses have been published for this article.